Premium
Wave Life Sciences Ltd (WVE)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-03-26 | RA Capital Management, L.P.Société | 8,77M | 54,62M | Achat | 6,06 - 6,50 | 26,98M | 48,19% |
| 2026-03-26 | RA Capital Management, L.P.Société | 8,77M | 54,62M | Achat | 6,06 - 6,50 | 26,98M | 48,19% |
| 2026-03-23 | Shin Nippon Biomedical Laboratories, Ltd.Société | 3,90M | 0,00 | Derivative Exercise and Retained Stock | - | 9,61M | 68,38% |
| 2026-02-26 | Dr. Christopher FrancisSenior VP of Corporate Development & Head of Emerging Areas | -33,19k | 357,67k | Derivative Exercise and Sale | 3,87 - 15,09 | 4,37k | - |
| 2026-02-09 | Mr. Kyle B. MoranCFO & Principal Accounting Officer | -3,59k | 48,26k | Vente | 13,45 | 57,26k | -5,90% |
| 2026-02-09 | Dr. Paul B. BolnoPresident, CEO & Director | -10,48k | 140,96k | Vente | 13,45 | 19,77k | -34,64% |
| 2026-02-09 | Dr. Christopher FrancisSenior VP of Corporate Development & Head of Emerging Areas | -1,88k | 25,33k | Vente | 13,45 | 4,37k | -30,13% |
| 2026-02-09 | Dr. Chandra VargeeseCTO | -3,23k | 43,42k | Vente | 13,45 | 334,87k | -0,95% |
| 2026-01-02 | Dr. Christopher FrancisSenior VP of Corporate Development & Head of Emerging Areas | -9,38k | 120,82k | Derivative Exercise and Sale | 3,14 - 16,70 | 25,00k | - |
| 2025-12-11 | GSK Equity Investments, LimitedSociété | 1,47M | 27,93M | Achat | 19,00 | - | - |
| 2025-12-08 | Dr. Christopher FrancisSenior VP of Corporate Development & Head of Emerging Areas | -441,03k | 4,32M | Derivative Exercise and Sale | 2,83 - 16,00 | 25,00k | - |
| 2025-12-08 | Mr. Adrian George RawcliffeIndependent Director | -42,00k | 379,26k | Derivative Exercise and Sale | 5,97 - 15,00 | 12,70k | - |
| 2025-12-09 | Mr. Kyle B. MoranCFO & Principal Accounting Officer | 36,00k | 294,12k | Derivative Exercise and Retained Stock | 8,17 | 48,37k | 291,14% |
| 2025-12-08 | Mr. Kyle B. MoranCFO & Principal Accounting Officer | -260,00k | 2,86M | Derivative Exercise and Sale | 2,83 - 20,03 | 48,37k | - |
| 2025-12-09 | Mr. Kyle B. MoranCFO & Principal Accounting Officer | -36,00 | 729,00 | Automatic Disposition | 20,25 | 48,37k | -0,07% |
| 2025-12-08 | Ms. Aik Na TanIndependent Director | -119,23k | 1,04M | Derivative Exercise and Sale | 3,50 - 15,00 | 0,00 | - |
| 2025-12-08 | Ms. Aik Na TanIndependent Director | -14,99k | 207,96k | Vente | 12,75 - 15,00 | 0,00 | -100,00% |
| 2025-12-08 | Dr. Gregory L. VerdineFounder & Director | -20,00k | 269,46k | Automatic Disposition | 13,09 - 14,05 | 262,52k | -7,08% |
| 2025-12-08 | Dr. Mark H. N. CorriganIndependent Director | -16,12k | 217,30k | Automatic Disposition | 13,09 - 14,07 | 0,00 | -100,00% |
| 2025-12-08 | Mr. Christian O. HenryIndependent Chairperson | -87,00k | 846,36k | Derivative Exercise and Sale | 3,50 - 18,02 | 0,00 | - |
| 2025-12-08 | Mr. Christian O. HenryIndependent Chairperson | -6,45k | 82,17k | Automatic Disposition | 12,75 | 0,00 | -100,00% |
| 2025-12-08 | Ms. Heidi L. WagnerIndependent Director | -14,00k | 105,42k | Derivative Exercise and Sale | 5,97 - 14,00 | 16,12k | - |
| 2025-11-13 | Mr. Adrian George RawcliffeIndependent Director | -16,12k | 109,42k | Automatic Disposition | 6,79 | 0,00 | -100,00% |
| 2025-11-13 | RA Capital Management, L.P.Société | 1 000,00 | 6,69k | Achat | 6,69 | 18,20M | 0,01% |
| 2025-11-13 | RA Capital Management, L.P.Société | 1 000,00 | 6,69k | Achat | 6,69 | 18,20M | 0,01% |
| 2025-08-22 | Dr. Paul B. BolnoPresident, CEO & Director | -217,35k | 2,19M | Automatic Disposition | 10,10 | 0,00 | -100,00% |
| 2025-08-22 | Dr. Gregory L. VerdineFounder & Director | -10,00k | 100,00k | Automatic Disposition | 10,00 | 272,52k | -3,54% |
| 2025-08-15 | Ms. Aik Na TanIndependent Director | -21,00k | 2,52k | Derivative Exercise and Sale | 9,13 - 9,25 | 14,99k | - |
| 2025-08-13 | Mr. Christian O. HenryIndependent Chairperson | -9,67k | 85,19k | Automatic Disposition | 8,81 | 16,95k | -36,33% |
| 2025-08-05 | Ms. Aik Na TanIndependent Director | -1,13k | 9,86k | Automatic Disposition | 8,75 | 14,99k | -6,99% |
| 2025-08-05 | Mr. Ken TakanashiIndependent Director | -4,87k | 42,63k | Automatic Disposition | 8,75 | 11,24k | -30,23% |
| 2025-06-13 | Dr. Gregory L. VerdineFounder & Director | -30,00k | 208,50k | Automatic Disposition | 6,95 | 266,40k | -10,12% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
